SHAILY Q1 FY27 Guidance vs Delivery (SHAILY Management Mirror)

Healthcare Revenue Performance Leads Q1 FY27 at INR 142 Crore, Up 85% YoY

The Healthcare segment delivered robust performance in Q1 FY27, reporting revenue of INR 142 crores, an 85% YoY increase compared to INR 77 crores in Q1 FY26. The segment contributed approximately 51% of consolidated revenue, making it the company's largest business segment for the quarter. Growth was primarily led by the pen injector platform, including devices used for GLP-1 and other chronic therapies. In FY26, Healthcare segment revenue surged 139% YoY to INR 393 crores, contributing 40% of consolidated revenue (up from 21% in FY25), with Q4 FY26 revenue doubling YoY to INR 113 crores. In 9M FY26, Healthcare revenue grew 158% YoY to INR 280 crores, and Q3 FY26 revenue grew 139% YoY to INR 104 crores.